“Part 11 certified”
What buyers usually see
A badge on the home page. No authority issues one, and the buyer's quality team knows it.
With VayoMed
Each requirement stated beside the function that supports it, with the regulation linked.
A clinical operations lead comparing EDC, eTMF or RTSM vendors wants to know what an inspector will ask of the system, what a new guideline changes in a study build, and how to test a vendor before signing. VayoMed researches and publishes those answers for you, and runs the website, press releases and LinkedIn around them, as one annual subscription.
$24K/year. Website, research, press releases, LinkedIn, domains and AI visibility.
What trial teams asked to see
100%of demo requests came with a company name and a phone number
Demo requests to a clinical trial software company, September and October 2026. Name withheld. Shares of the demo requests received, counted on November 17, 2026, after removing test submissions.
The demo requests our client received came from site coordinators, clinical operations, data management and medical affairs. These are the questions those people work through first.
What they look for
How the system handles audit trails, electronic signatures and certified copies under 21 CFR Part 11 and ICH E6(R3).
What we build
Reports built from FDA inspection findings and warning letters on what inspectors ask of computerized systems, and a trust page that states what you hold.
What they look for
A plain account of EDC, CTMS, eTMF, RTSM and eCOA, and which of them a trial of their size requires.
What we build
A platform page and a page for each module, and a module map for small sponsors derived from registry data.
What they look for
Checks they can run themselves in a demo or during user acceptance testing.
What we build
Acceptance scripts published as reports: how to test inspection readiness in a vendor demo, or the handoff between sponsor and CRO systems.
What they look for
Their own design: oncology with central review, CNS trials with rater training, decentralised elements, device investigations, sites in several regions.
What we build
A report for each trial type you want to be chosen for, built from the registries and the guidance that governs it.
What they look for
ICH E6(R3), the ICH M11 protocol template, new FDA guidance, EU results disclosure. They want to know what it means for a study build.
What we build
A report every week and a press release every month on each change and what it requires of the systems.
What they look for
How an AI function was qualified, for which use, and what the audit trail records.
What we build
A qualification guide for AI functions in clinical trial software, and a weekly reading of how AI assistants describe your product.
An inspector asks the sponsor how a system was validated, not the vendor for a badge. Buyers know this, and a claim they cannot check counts against you. Every statement we publish for you names the requirement and links its source.
What buyers usually see
A badge on the home page. No authority issues one, and the buyer's quality team knows it.
With VayoMed
Each requirement stated beside the function that supports it, with the regulation linked.
What buyers usually see
“Database lock 40% faster”, with nothing a buyer can verify.
With VayoMed
Figures come from public registries and inspection data, with the source linked, or they are left out.
What buyers usually see
A wall of sponsor names, some of whom never agreed to be listed.
With VayoMed
Evidence by trial type and phase. No sponsor of yours is named.
We publish long, sourced reports on the questions your buyers are evaluating. For a clinical trial software client those reports are built from public records like these, and every source is linked.
ClinicalTrials.gov and the EU trial registry
How trials are actually designed: endpoints, countries, instruments, and what must be disclosed.
FDA inspection data and warning letters
What inspectors cite about records, monitoring and computerized systems.
ICH guidelines
What E6(R3), M11 and the other guidelines require of a study build.
21 CFR Part 11 and Part 312
The record-keeping and electronic-records rules a system has to support.
FDA and EMA guidance
What a new guidance changes, and from when.
CDISC standards
How instruments and outcomes map to the data a system has to deliver.
National rules for trial data
What changes when a trial runs sites in several regions.
Published studies
The evidence behind a design choice, such as central review or rater training.
Each of these is a kind of report we have published for a client.
Reports average about 6,100 words and 17 linked sources.
Everything below is included in the subscription. We do the work. You decide how much you review: approve each piece before it goes out, or read it once it is live.
Built once, run every day
Built or rebuilt around your platform, with a page for each module and each solution, a trust page and a demo request form. Hosting, updates and analytics stay with us.
How the website worksEvery week
Long reports on the questions sponsors, CROs and sites are evaluating, built from registries, inspection data and guidance, and published on your site.
How research worksEvery month
Written from the research and distributed. Each of our last 11 releases was published by 274 to 311 news sites.
How PR worksPlanned two weeks ahead
Posts made from your research and your product, so clinical operations and data managers see something useful, not a product advert.
How LinkedIn worksEvery Monday
How AI assistants answer your buyers' questions: where you are named, where competitors are, and which sources were cited. One in ten of a client's demo requests had a recorded ChatGPT referral.
How tracking worksAs they arrive
The form asks for the role and the module of interest. Each request arrives in your workspace with its recorded source and the pages the visitor read, when those were recorded.
See the workspaceRead from our own lead records, publishing records and distribution reports on November 17, 2026. The client joined in August 2026.
The order is fixed; the dates depend on how quickly material and reviews come back.
01Weeks 1–2
We write down your modules, the requirement each function supports, the trial types you serve and the claims to avoid. We take the first AI-visibility reading and open your workspace.
02Month 1
The first research report is written and the first press release is drafted. Your LinkedIn page is reworked and the first two-week plan is made.
03Months 1–2
The site is built or rebuilt around your platform and modules and launched on your domain, with the demo form and analytics live.
04Month 3 onwards
A report every week, a release every month, LinkedIn on a two-week plan, AI visibility every Monday, and a summary every quarter.
This is not software your team has to run. We build the website, publish the research, send the releases, manage LinkedIn and report the results. You see and steer all of it in your client workspace.
Included
Priced separately
Premium placement in named business and technology outlets: from $2,000 per placement.
Done-for-You annual subscription
$24K/ year
12-month agreement. Equivalent to $2,000 per month; monthly billing or annual prepayment, as agreed.
The comparable traditional route is estimated at $200–300K+ a year across writers, PR agencies and wire distribution.
We write from the regulation, the guidance and public inspection and registry data, and link every source so your team can check a claim in a minute. For our client the reports cite ICH guidelines, FDA and EMA guidance, FDA inspection data, ClinicalTrials.gov and the EU trial registry.
Every demo request a client received in September and October 2026 came with a company name and a phone number. 30% asked for the whole platform, 30% for EDC, 20% for CTMS, 10% for eCOA and 10% for scale management and rater training, from site coordinators, clinical operations, data management and medical affairs. We do not promise a number.
No. We show what the system is for by trial type and phase. A sponsor is named only if you give us a public reference to use.
They are who the reports are written for. Each one answers a working question, such as how to test inspection readiness in a demo, and gives the reader something to use: a script, a checklist or a table drawn from the public record.
The United States by default: we read how AI assistants answer your buyers' questions there every week.
Product documentation, the list of modules and the requirements they support, brand files and screenshots. After onboarding, a reviewer who answers within a few days.
$24,000 a year for everything on this page, on a 12-month agreement, billed monthly or prepaid annually as agreed.
The free report is a snapshot of your domain: search rankings, estimated search traffic and where the web mentions you. Enter your domain, confirm your email, and we email you the link.